Primrose syndrome

Primrose syndrome is a rare genetic disorder characterized by a variety of physical, developmental, and neurological abnormalities. The condition was first described by Dr. David A. Primrose in 1982. Individuals with Primrose syndrome often present with distinctive facial features, hearing loss, intellectual disability, and other systemic manifestations.
Presentation[edit]
The clinical features of Primrose syndrome can vary widely among affected individuals. Common characteristics include:
- Macrocephaly (an abnormally large head)
- Hearing loss
- Intellectual disability
- Muscle weakness
- Joint contractures
- Diabetes mellitus
- Calcification of the external ears
- Autism spectrum disorder
Genetics[edit]
Primrose syndrome is caused by mutations in the ZBTB20 gene, which plays a role in the development and function of various tissues in the body. The condition is inherited in an autosomal dominant manner, meaning that a single copy of the mutated gene is sufficient to cause the disorder.
Diagnosis[edit]
Diagnosis of Primrose syndrome is based on clinical evaluation, identification of characteristic features, and genetic testing to confirm mutations in the ZBTB20 gene. Differential diagnosis may include other syndromes with overlapping features, such as Sotos syndrome and Weaver syndrome.
Management[edit]
There is no cure for Primrose syndrome, and treatment is symptomatic and supportive. Management may involve a multidisciplinary approach, including:
- Audiology services for hearing loss
- Physical therapy for muscle weakness and joint contractures
- Endocrinology for diabetes management
- Special education services for intellectual disability
- Behavioral therapy for autism spectrum disorder
Prognosis[edit]
The prognosis for individuals with Primrose syndrome varies depending on the severity of symptoms and the presence of associated complications. Early intervention and supportive care can improve the quality of life for affected individuals.
See also[edit]
References[edit]
External links[edit]
-
| Medical condition
|
|---|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian